BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 10, 2020
View Archived Issues
Keeping stem cells quiescent enables greater ultimate potency
Read More
BioPROTACs cut out middleman, and small molecule
Read More
Tumor mutational burden correlates with high-MSI patients in CRC
Read More
SS18-SSX fusion-specific Ab for the diagnosis of synovial sarcoma
Read More
Nanoform and Orion establish drug-development collaboration
Read More
Zhuhai United Laboratories patents new JAK1 and/or TYK2 inhibitors
Read More
Primary endpoint missed in ELOQUENT-1 study of Empliciti in newly diagnosed multiple myeloma
Read More
CROI in the time of COVID-19: Researchers phoning it in at all-virtual 2020 CROI
Read More
TRPV4 found expressed in cartilaginous tumors and may be a potential therapeutic target
Read More
Kala reports promising topline data from STRIDE 3 study of Eysuvis in dry eye disease
Read More
CEL-SCI applies its LEAPS peptide technology to develop immunotherapy against COVID-19
Read More
AbbVie partners with global authorities to evaluate HIV drug for treatment of COVID-19
Read More
Dare presents data in support of sildenafil cream for female sexual arousal disorder
Read More
Encouraging 48-week data from phase III ATLAS-2M study of long-acting HIV regimen
Read More
MDM2 and CDK4 predict metastasis in Leydig cell tumors
Read More
MediciNova to develop MN-166 for severe pneumonia and ARDS
Read More
U.S. researchers present CDK8 or CDK19 inhibitors
Read More
Terns discloses new THRB agonists for NASH
Read More
Clavius Pharmaceuticals synthesizes new TGFBR1 inhibitors
Read More
Atomwise and Bridge Biotherapeutics establish AI-based research collaboration
Read More
Santen and Tracon discontinue development of DE-122 for wet AMD following phase IIa results
Read More
Acceleron ends development of ACE-083 following phase II results in Charcot-Marie-Tooth disease
Read More
Ascletis offers update on Chinese trial of Ganovo and ritonavir for novel coronavirus pneumonia
Read More
FDA approves Ofev for chronic fibrosing interstitial lung diseases with a progressive phenotype
Read More
IPH-5201 begins first-in-human study in advanced solid tumors
Read More
